Statistical methods in clinical trials

Val J Gebski and Anthony C Keech
Med J Aust 2003; 178 (4): . || doi: 10.5694/j.1326-5377.2003.tb05139.x
Published online: 17 February 2003

Appropriate statistical methods for analysing trial data are critical for the correct interpretation of the results. Item 12 of the CONSORT statement (Box 1) relates to the statistical methods used in the reporting of trials, together with scientific and statistical principles concerning analyses of subgroups, endpoints and appropriate statistical tests. These issues need to be carefully considered before beginning a study and should be outlined in a standard trial protocol, which may be supplemented by a more extensive statistical analysis plan.1

  • NHMRC Clinical Trials Centre, University of Sydney, Camperdown, NSW.


Competing interests:

None identified.

  • 1. Altman DG, Schulz KF, Moher D, et al, for the CONSORT group. The revised CONSORT statement for reporting randomised trials: explanation and elaboration. Ann Intern Med 2001; 134: 663-694.
  • 2. Gebski V, Marschner I, Keech AC. Specifying objectives and outcomes for clinical trials. Med J Aust 2002; 176: 491-492. <eMJA full text>
  • 3. Kirby A, Gebski V, Keech A. Determining the sample size in a clinical trial. Med J Aust 2002; 176: 256-257.<eMJA full text>
  • 4. Gebski V, Beller E, Keech AC. Randomised controlled trials, the elements of a good study. Med J Aust 2001; 175: 272-274.
  • 5. Woodward M. Epidemiology: study design and data analysis. Boca Raton: Chapman and Hall/CRC Press, 1999.
  • 6. Delaney G, Rus M, Gebski V, et al. An Australasian assessment of the basic treatment equivalent model derived from NSW data. Australas Radiol 1999; 43: 500-506.
  • 7. Simes RJ, Greatorex V, Gebski VJ. Practical approaches to minimise problems with missing quality of life data. Stat Med 1998; 17: 725-737.
  • 8. Hollander M, Wolf D. Nonparametric statistical methods. 2nd Ed. New York: John Wiley and Sons, 1999.
  • 9. Martin G. Munchausen's statistical grid, which makes all trials significant. Lancet 1984; ii: 1457.


remove_circle_outline Delete Author
add_circle_outline Add Author

Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.